Respiratory failure future or investigational therapies

Jump to navigation Jump to search

Respiratory failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Respiratory Failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Electrocardiogram

CT

MRI

Echocardiography and ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical therapy

Oxygen therapy

Mechanical ventilation

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Respiratory failure future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Respiratory failure future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Respiratory failure future or investigational therapies

CDC on Respiratory failure future or investigational therapies

Respiratory failure future or investigational therapies in the news

Blogs on Respiratory failure future or investigational therapies

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Respiratory failure future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Overview

Noninvasive pressure support ventilation (NPSV) using a new special helmet has undergone a pilot trial, where it successfully treated hypoxemic ARF, with a higher tolerance and less complications than a conventional face mask.

Future or Investigational Therapies

Noninvasive pressure support ventilation (NPSV) using a new special helmet has undergone a pilot trial, where it successfully treated hypoxemic ARF, with a higher tolerance and less complications than a conventional face mask.[1]


References

  1. Antonelli M, Conti G, Pelosi P, Gregoretti C, Pennisi MA, Costa R, Severgnini P, Chiaranda M, Proietti R (March 2002). "New treatment of acute hypoxemic respiratory failure: noninvasive pressure support ventilation delivered by helmet--a pilot controlled trial". Crit. Care Med. 30 (3): 602–8. PMID 11990923.

Template:WH Template:WS